Feedback / Questions
Dasynoc (dasatinib amorphous) - Xspray Pharma
https://xspraypharma.com/modular_finance_pressmeddelande/fda-sets-pdufa-date-for-xspray-pharmas-re-submitted-application-for-dasynoc/
May 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next